NO875181D0 - Substituerte aminopropionsyreamider, fremgangsmaate til deres fremstilling, midler inneholdende disse og deres anvendelse, samt de ved fremstillingen dannede nye mellomprodukter. - Google Patents

Substituerte aminopropionsyreamider, fremgangsmaate til deres fremstilling, midler inneholdende disse og deres anvendelse, samt de ved fremstillingen dannede nye mellomprodukter.

Info

Publication number
NO875181D0
NO875181D0 NO875181A NO875181A NO875181D0 NO 875181 D0 NO875181 D0 NO 875181D0 NO 875181 A NO875181 A NO 875181A NO 875181 A NO875181 A NO 875181A NO 875181 D0 NO875181 D0 NO 875181D0
Authority
NO
Norway
Prior art keywords
products
procedures
needed
preparation
acid amides
Prior art date
Application number
NO875181A
Other languages
English (en)
Norwegian (no)
Inventor
Rudolf Kunstmann
Franz Hock
Gabriele Wiemer
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of NO875181D0 publication Critical patent/NO875181D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/15—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C07D209/16—Tryptamines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/14—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Psychiatry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Furan Compounds (AREA)
  • Pyridine Compounds (AREA)
NO875181A 1986-12-12 1987-12-11 Substituerte aminopropionsyreamider, fremgangsmaate til deres fremstilling, midler inneholdende disse og deres anvendelse, samt de ved fremstillingen dannede nye mellomprodukter. NO875181D0 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19863642497 DE3642497A1 (de) 1986-12-12 1986-12-12 Substituierte aminopropionsaeureamide, verfahren zu ihrer herstellung, diese enthaltende mittel und ihre verwendung sowie die bei der herstellung anfallenden neuen zwischenprodukte

Publications (1)

Publication Number Publication Date
NO875181D0 true NO875181D0 (no) 1987-12-11

Family

ID=6316060

Family Applications (1)

Application Number Title Priority Date Filing Date
NO875181A NO875181D0 (no) 1986-12-12 1987-12-11 Substituerte aminopropionsyreamider, fremgangsmaate til deres fremstilling, midler inneholdende disse og deres anvendelse, samt de ved fremstillingen dannede nye mellomprodukter.

Country Status (17)

Country Link
EP (1) EP0271099A3 (da)
JP (1) JPS63185948A (da)
KR (1) KR880007490A (da)
AU (1) AU8246087A (da)
DE (1) DE3642497A1 (da)
DK (1) DK651987A (da)
FI (1) FI875432A7 (da)
HU (1) HUT45486A (da)
IL (1) IL84791A0 (da)
JO (1) JO1521B1 (da)
MA (1) MA21130A1 (da)
MT (1) MTP1014B (da)
NO (1) NO875181D0 (da)
OA (1) OA08699A (da)
PT (1) PT86344B (da)
TN (1) TNSN87138A1 (da)
ZA (1) ZA879330B (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5039805A (en) * 1988-12-08 1991-08-13 Hoffmann-La Roche Inc. Novel benzoic and phenylacetic acid derivatives
US5149817A (en) * 1990-03-05 1992-09-22 Shionogi & Co., Ltd. Teirahydropyridine derivatives
US5189179A (en) 1990-08-29 1993-02-23 Merrell Dow Pharmaceuticals Inc. Serotonin 5ht1a agonists
WO1993013766A1 (en) * 1992-01-07 1993-07-22 Merrell Dow Pharmaceuticals Inc. Treatment of involuntary movements with 5ht1a receptor agonists
EP1118612A1 (en) * 2000-01-21 2001-07-25 Universita Degli Studi di Firenze Piperazine derivatives possesing nootropic activity
FR2976942B1 (fr) * 2011-06-23 2013-07-12 Metabolys Derives de piperazine, leurs procedes de preparation et leurs utilisations dans le traitement de l'insulinoresistance
CN111116451A (zh) * 2020-01-16 2020-05-08 宁波大学 一种多取代色胺基苯甲酰胺类化合物及其制备方法和用途
CN115322131B (zh) * 2022-04-21 2023-08-22 温州大学 β-氟代吲哚丙烯酰胺化合物的合成方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8303946D0 (en) * 1983-02-12 1983-03-16 Recordati Chem Pharm Antihypertensive n-piperazinylalkanoylanilides
DE3500898A1 (de) * 1985-01-12 1986-07-17 Hoechst Ag, 6230 Frankfurt Neue propionsaeureamide mit saeuresekretionshemmender wirkung, verfahren zu ihrer herstellung, diese enthaltende mittel und ihre verwendung

Also Published As

Publication number Publication date
OA08699A (fr) 1989-03-31
DE3642497A1 (de) 1988-06-23
FI875432A7 (fi) 1988-06-13
ZA879330B (en) 1988-07-27
PT86344A (de) 1988-01-01
KR880007490A (ko) 1988-08-27
IL84791A0 (en) 1988-05-31
MTP1014B (en) 1989-07-18
DK651987D0 (da) 1987-12-11
DK651987A (da) 1988-06-13
EP0271099A2 (de) 1988-06-15
HUT45486A (en) 1988-07-28
MA21130A1 (fr) 1988-07-01
EP0271099A3 (de) 1989-05-03
JO1521B1 (en) 1989-01-25
FI875432A0 (fi) 1987-12-10
TNSN87138A1 (fr) 1990-01-01
AU8246087A (en) 1988-08-18
JPS63185948A (ja) 1988-08-01
PT86344B (pt) 1990-11-07

Similar Documents

Publication Publication Date Title
NO171364C (no) N-aryl-3-aryl-4,5-dihydro-1h-pyrazol-1-karboksamider og fremgangsmaate til fremstilling derav, samt insektmiddel sominneholder karboksamidet
NO163962C (no) Flytende vaskemiddel og fremgangsmaate for fremstilling avdette.
DK61189A (da) Stabilt, vaeskeformigt vaskemiddel og toejbloedgoeringsmiddel samt fremgangsmaade til fremstilling heraf
DK160052C (da) Chlorsubstituerede disaccharider og fremgangsmaader til fremstilling deraf samt praeparater indeholdende sacchariderne som soedemidler
DK213085D0 (da) Aminotetralinderivater, laegemidler indeholdende disse og fremgangsmaade til forbindelsernes fremstilling
DK362787D0 (da) Benzensulfonamido-indanylforbindelser, laegemidler indeholdende disse forbindelser og fremgangsmaade til deres fremstilling
DK318088A (da) Vaeskeformig, vandig detergentsammensaetning og fremgangsmaade til fremstilling af samme
DE3689600D1 (de) Viskoelastische Lösung.
DK310186D0 (da) N-alkylphenyl-maleimider og termohaerdelige formstof-blandinger indeholdende saadanne, samt fremgangsmaade til fremstilling deraf
NO875263D0 (no) 2,3-disubstituerte isoksazolidiner, fremgangsmaate til deres fremstilling, midler inneholdende disse og deres anvendelse.
DK613886A (da) 5-heterocyclyl-1-arylpyrazoler, deres fremstilling og anvendelse som skadedyrsbekaempelsesmidler samt fremstilling og mellemprodukter og disses anvendelse
FI820061A7 (fi) Uudet karboksyylihappoamidit, niiden valmistus ja niiden käyttö lääkeaineina.
DK13686A (da) Cephemderivat, fremgangsmaade til fremstilling deraf og mellemprodukt samt fremgangsmaade til fremstilling deraf
DK170986A (da) Substituerede 2,3,4,9-tetrahydro-1h-carbazol-1-eddikesyre-derivater, deres fremstilling og anvendelse som famaceutika samt mellem-produkter ved fremstillingen
NO165639C (no) Oksalkylerte polyesteraminer, fremgangsmaate til deres fremstilling, og deres anvendelse.
NO862997D0 (no) Stabilisert, enzymholdig og bygget flytende vaskemiddel.
DK579786A (da) Imidazopyridazinalkensyreamider, deres fremstilling og anvendelse samt mellemprodukter til brug ved fremstillingen
DK457787A (da) Sulfonamidoethylforbindelser, laegemidler indeholdende disse forbindelser og fremgangsmaade til deres fremstilling
DK361288D0 (da) Hydroxyethylazolylderivater, deres fremstilling og anvendelse samt mellemprodukter til fremstilling og disses fremstilling
DK651987A (da) Substituerede aminopropionsyreamider, deres fremstilling og anvendelse samt ved fremstillingen anvendelige mellemprodukter
ATE49102T1 (de) Herbizide mittel.
NO862917D0 (no) Dihydrokinolinon-derivater, fremgangsmaate til deres fremstilling, legemidler som inneholder disse og deres anvendelse, samt mellomprodukter til deres fremstilling.
DE3675155D1 (de) Sulfoalkylierungsverfahren.
DK142586A (da) Anvendelse af efomyciner som praestationsfremmende stoffer til dyr, efomyciner og deres fremstilling, samt ved fremstillingen anvendelige mikroorganismer
DK410185A (da) 7-oxo-4-thia-1-azabicyclo(3,2,0)hept-2-en-derivater, deres fremstilling og anvendelse som laegemiddel, samt ved fremstillingen anvendelige mellemprodukter